Predictions
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.49
23.09.22
23.09.22
€80.00
31.07.25
31.07.25
28.12%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€15.08
21.09.22
21.09.22
-
21.09.23
21.09.23
-4.44%
01.10.22
01.10.22
Risky Investment
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€0.78
21.09.22
21.09.22
€3.00
30.04.23
30.04.23
87.12%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma
Start price
Target price
Perf. (%)
€1.88
20.09.22
20.09.22
€1.60
20.09.23
20.09.23
-7.46%
03.10.22
03.10.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.17
20.09.22
20.09.22
-
20.09.23
20.09.23
-15.38%
15.10.22
15.10.22
Risky Investment
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€16.65
20.09.22
20.09.22
€32.00
31.01.23
31.01.23
-17.72%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.18
20.09.22
20.09.22
€7.00
31.08.25
31.08.25
32.08%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.64
19.09.22
19.09.22
€17.00
19.09.23
19.09.23
-34.41%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.21
19.09.22
19.09.22
-
19.09.23
19.09.23
-12.19%
01.10.22
01.10.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€6.20
19.09.22
19.09.22
-
19.09.23
19.09.23
-18.43%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.36
19.09.22
19.09.22
€130.00
19.09.23
19.09.23
-8.59%
20.09.23
20.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
Athersys Inc.
Start price
Target price
Perf. (%)
€1.87
19.09.22
19.09.22
€3.80
19.09.23
19.09.23
0.19%
17.10.22
17.10.22
Could be very worthwhile Investment >20% year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€16.96
18.09.22
18.09.22
-
18.09.23
18.09.23
144.16%
18.05.23
18.05.23
Risky Investment
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€17.43
18.09.22
18.09.22
-
18.09.23
18.09.23
-17.30%
01.10.22
01.10.22
Risky Investment
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€7.79
17.09.22
17.09.22
€3.00
17.09.23
17.09.23
-22.91%
01.10.22
01.10.22
High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.40
15.09.22
15.09.22
€8.00
15.09.23
15.09.23
-1.52%
17.09.22
17.09.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.40
15.09.22
15.09.22
€11.00
15.09.23
15.09.23
-1.52%
17.09.22
17.09.22
Differentiated customer and product portfolio
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€309.00
15.09.22
15.09.22
€550.00
15.09.23
15.09.23
74.76%
16.09.23
16.09.23
Athersys Inc.
Start price
Target price
Perf. (%)
€2.21
15.09.22
15.09.22
€4.60
15.09.23
15.09.23
-15.60%
19.09.22
19.09.22
Could be very worthwhile Investment >20% year
